Literature DB >> 29459256

Evaluation of data quality at the National Cancer Registry of Ukraine.

Anton Ryzhov1, Freddie Bray2, Jacques Ferlay2, Zoya Fedorenko3, Liudmyla Goulak3, Yevgeniy Gorokh3, Olena Soumkina3, Ariana Znaor4.   

Abstract

BACKGROUND: Cancer notification has been mandatory in Ukraine since 1953, with the National Cancer Registry of Ukraine (NCRU) established in 1996. The aim of this study was to provide a comprehensive evaluation of the data quality at the NCRU.
METHODS: Qualitative and semi-quantitative methods were used to assess the comparability, completeness, validity and timeliness of cancer incidence data from the NCRU for the period 2002-2012.
RESULTS: Cancer registration procedures at the NCRU are in accordance with international standards and recommendations. Semi-quantitative methods suggested the NCRU's data was reasonably complete, although decreases in age-specific incidence and mortality rates in the elderly indicated some missing cases at older ages. The proportion of microscopically-verified cases increased from 73.6% in 2002 to 82.3% in 2012, with death-certificate-only (DCO) proportions stable at around 0.1% and unknown stage recorded in 9.6% of male and 7.5% of female solid tumours. Timeliness was considered acceptable, with reporting >99% complete within a turn-around time of 15 months.
CONCLUSION: While timely reporting of national data reflects the advantages of a mandatory data collection system, a low DCO% and observed age-specific declines suggest possible underreporting of incidence and mortality data, particularly at older ages. Overall, the evaluation indicates that the data are reasonably comparable and thus may be used to describe the magnitude of the cancer burden in Ukraine. Given its central role in monitoring and evaluation of cancer control activities, ensuring the sustainability of NCRU operations throughout the process of healthcare system reform is of utmost importance.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer registry; Comparability; Completeness; Data quality; Timeliness; Ukraine; Validity

Mesh:

Year:  2018        PMID: 29459256     DOI: 10.1016/j.canep.2018.02.002

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  5 in total

1.  Breast cancer incidence in the regions of Belarus and Ukraine most contaminated by the Chernobyl accident: 1978 to 2016.

Authors:  Ljubica Zupunski; Alesia Yaumenenka; Anton Ryzhov; Ilya Veyalkin; Vladimir Drozdovitch; Sergii Masiuk; Olha Ivanova; Ausrele Kesminiene; Eero Pukkala; Pavel Moiseev; Anatoly Prysyazhnyuk; Joachim Schüz; Evgenia Ostroumova
Journal:  Int J Cancer       Date:  2020-10-29       Impact factor: 7.316

2.  Trends in Solid Tumor Incidence in Ukraine 30 Years After Chernobyl.

Authors:  Krystle M Leung; Galyna Shabat; Pamela Lu; Adam C Fields; Andrey Lukashenko; Jennifer S Davids; Nelya Melnitchouk
Journal:  J Glob Oncol       Date:  2019-08

3.  Cancers after Chornobyl: From Epidemiology to Molecular Quantification.

Authors:  Dimitry Bazyka; Natalya Gudzenko; Iryna Dyagil; Iryna Ilienko; David Belyi; Vadim Chumak; Anatoly Prysyazhnyuk; Elena Bakhanova
Journal:  Cancers (Basel)       Date:  2019-09-02       Impact factor: 6.639

4.  Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study.

Authors:  Anton Ryzhov; Marilys Corbex; Marion Piñeros; Anton Barchuk; Diana Andreasyan; Sayde Djanklich; Vadim Ghervas; Olga Gretsova; Dilyara Kaidarova; Konstantin Kazanjan; Fuad Mardanli; Yuriy Michailovich; Elena Ten; Alesya Yaumenenka; Freddie Bray; Ariana Znaor
Journal:  Lancet Oncol       Date:  2021-02-05       Impact factor: 41.316

5.  Colorectal Cancer in Ukraine: Regional Disparities and National Trends in Incidence, Management, and Mortality.

Authors:  Nelya Melnitchouk; Galyna Shabat; Pamela Lu; Heather Lyu; Rebecca Scully; Krystle Leung; Molly Jarman; Andrey Lukashenko; Olena O Kolesnik; Joel Goldberg; Jennifer S Davids; Ronald Bleday
Journal:  J Glob Oncol       Date:  2018-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.